Related Experiment Video
Updated: Aug 12, 2026
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
Published on: April 11, 2018
Experimental approaches to treatment of soft tissue sarcoma
1Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Box 444, Houston, TX 77030, USA.
Abstract:
The experimental approaches described in this article represent potential new approaches for targeted therapy. Thus far, none of the preclinical data have demonstrated a cure for sarcomas; however, the antitumor effects of many of these new agents seem to be enhanced when the agents are combined with chemotherapeutic agents. The combination of novel therapeutics with conventional chemotherapy may be the most effective strategy in terms of maximization of tumor killing and minimization of toxicity and the risk of drug resistance. Not only are new drugs being developed for treatment of sarcomas but new ways of delivering drugs are also being investigated. The angiogenic, or metronomic, schedule of drug delivery may be preferable to conventional schedules in achieving optimal tumor inhibition. In addition, isolated limb perfusion is a unique approach to delivery of drugs, such as TNF and melphalan, for sarcomas and melanomas [137, 138]. The advantages of this method of drug delivery include the ability to administer therapeutic agents in high concentrations to a specific region of the body without systemic toxicity. Further advances in the understanding of the biology of sarcomas along with novel approaches to delivery of drugs are crucial to the development of new and effective therapies.
Insights
New targeted therapies show promise for sarcoma treatment, especially when combined with chemotherapy. Novel drug delivery methods, like metronomic dosing and isolated limb perfusion, also enhance antitumor effects while minimizing toxicity.
Area of Science:
- Oncology
- Pharmacology
- Cancer Therapeutics
Background:
- Sarcomas remain challenging to treat, with no current cure.
- Preclinical research is exploring novel targeted therapies and drug delivery systems.
Purpose of the Study:
- To review emerging experimental approaches for sarcoma treatment.
- To highlight the potential of combination therapies and innovative drug delivery methods.
Main Methods:
- Review of preclinical data on novel therapeutic agents for sarcomas.
- Investigation of combination strategies with conventional chemotherapy.
- Exploration of new drug delivery schedules (metronomic) and regional administration (isolated limb perfusion).
Main Results:
- New agents show enhanced antitumor effects when combined with chemotherapy.
- Combination therapy may maximize tumor killing and minimize toxicity and resistance.
- Metronomic schedules and isolated limb perfusion offer potential advantages in drug delivery.
Conclusions:
- Combination of novel therapeutics with conventional chemotherapy is a promising strategy.
- Innovative drug delivery methods like metronomic dosing and isolated limb perfusion warrant further investigation.
- Advances in sarcoma biology and drug delivery are critical for developing effective treatments.
